Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Imfinzi significantly reduces the risk of disease worsening or death in the Phase III PACIFIC trial for Stage III unresectable lung cancer
-
AstraZeneca provides update on STRATOS 1 Phase III trial of tralokinumab in severe, uncontrolled asthma
-
AstraZeneca and Pieris Pharmaceuticals collaborate to develop and commercialise Anticalin-based inhaled treatments for respiratory diseases
-
AstraZeneca’s Imfinzi (durvalumab) receives US FDA accelerated approval for previously treated patients with advanced bladder cancer
-
Q1 2017 Results
-
Tagrisso receives full approval in the EU
-
AstraZeneca marks a key milestone with the ‘topping out’ of new global R&D centre and HQ in Cambridge, UK
-
Tagrisso (osimertinib) receives US FDA full approval
-
AstraZeneca’s potential medicine for neuromyelitis optica spectrum disorder receives orphan designation in Europe
-
Astrazeneca to share its robust early science in oncology with the medical community at AACR 2017
Latest articles and press releases
All of our latest press releases and articles are available to explore
